Optimizing withdrawal strategies for anti-TNF-α therapies in rheumatoid arthritis

• Published in: Expert opinion on biological therapy Vol. 24; no. 8; p. 815
• Main Authors: Venetsanopoulou, Aliki I, Voulgari, Paraskevi V, Drosos, Alexandros A
• Format: Journal Article
• Language: English
• Published: England 02.08.2024
• Subjects: Antirheumatic Agents - administration & dosage; Antirheumatic Agents - adverse effects; Antirheumatic Agents - therapeutic use; Arthritis, Rheumatoid - drug therapy; Arthritis, Rheumatoid - immunology; Humans; Quality of Life; Tumor Necrosis Factor-alpha - antagonists & inhibitors; Tumor Necrosis Factor-alpha - immunology; withdrawal; biological treatment; dosage reduction; tumor necrosis factor-alpha inhibitors; Rheumatoid arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune disease that significantly impacts patients' quality of life. While treatment options have expanded over the years, including the introduction of tumor necrosis factor-alpha (TNFα) inhibitors (TNFi), optimizing withdrawal strategies for these ag...